Nearly all fatalities arising from breast tumors are attributable to distant metastases. Breast
cancer liver metastasis (BCLM) is associated with poor prognoses, with the median survival …

Breast cancer is the most common malignant tumor in women and the leading cause of
cancer death in women. About 30% of breast cancer patients have metastasis every year …

Background and purpose To summarize the clinical outcomes of stereotactic body
radiotherapy (SBRT) for metastatic breast cancer (mBC) from a large institution. Materials …

Background Currently, the outcomes of standard-of-care palliative treatment for BCLM
remain poor. Recent literature has shown promising results of hepatic resection, however …

Simple Summary Robust predictive and prognostic tools are needed in the management of
breast cancer liver metastases (BCLMs). Until now, surgery has not been the gold standard …

Abstract Aim/Purpose This study examines the impact of decision-making, crisis
management, and decision-making on sustainability through the mediation of open …

Background Oligometastatic breast cancer (OMBC) is characterized by limited metastatic
tumor numbers and sites. We have reported a 20-year overall survival (OS) rate and relapse …

Simple Summary Breast cancers diagnosed at an advanced stage are often incurable, and
systemic strategies such as chemotherapy, hormonotherapy, immunotherapy, and/or …

Improvements in systemic therapies along with radical treatment of the primary tumor and
metastatic lesions, together with optimization in the use of imaging tools, may help to …

Purpose The present study aimed to identify clinicopathological characteristics of breast
cancer liver metastasis (BCLM) as well as to characterize the risk and prognostic factors for …